(Q52542356)

3 May 2018

title

Circulating soluble CD4 directly prevents host resistance and delayed-type hypersensitivity response to Cryptococcus neoformans in mice. (English)

1 reference

3 May 2018

main subject

Cryptococcus neoformans

1 reference

1 reference

Kawakami K

1

1 reference

3 May 2018

Koguchi Y

2

1 reference

3 May 2018

Qureshi MH

3

1 reference

3 May 2018

Yara S

4

1 reference

3 May 2018

Kinjo Y

5

1 reference

3 May 2018

Miyazato A

6

1 reference

3 May 2018

Nishizawa A

7

1 reference

3 May 2018

Nariuchi H

8

1 reference

3 May 2018

Saito A

9

1 reference

3 May 2018

publication date

1 January 2000

1 reference

3 May 2018

Microbiology and Immunology

published in

1 reference

3 May 2018

volume

44

1 reference

3 May 2018

issue

12

1 reference

3 May 2018

page(s)

1033-1041

1 reference

3 May 2018

Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

Soluble CD4 suppress the antigen driven proliferative response of certain T cell clones specific for mycobacteria and for peptides by mycobacterial heat shock proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

Effect of recombinant soluble CD4 on human peripheral blood lymphocyte responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

Naturally occurring soluble CD4 in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

CD4+ T-lymphocytes are not required for murine resistance to the human filarial parasite, Brugia malayi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

The Walter Reed staging classification for HTLV-III/LAV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02600.X

10.1111/J.1348-0421.2000.TB02600.X

21 January 2018

Identifiers

DOI

1 reference

3 May 2018

1 reference

3 May 2018